Bg pattern

GLUCOSAMINE KERN PHARMA 1500 mg POWDER FOR ORAL SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use GLUCOSAMINE KERN PHARMA 1500 mg POWDER FOR ORAL SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

PACKAGE LEAFLET: INFORMATION FOR THE USER

Glucosamine Kern Pharma 1,500 mg powder for oral solution EFG

Glucosamine sulfate

Read all of this leaflet carefully before you start taking this medicine.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you. Do not pass it on to others, as it may harm them, even if their symptoms are the same as yours.
  • If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

Contents of the pack:

  1. What Glucosamine Kern Pharma is and what it is used for.
  2. Before taking Glucosamine Kern Pharma.
  3. How to take Glucosamine Kern Pharma.
  4. Possible side effects.
  5. Storage of Glucosamine Kern Pharma.
  6. Further information.

1. What Glucosamine Kern Pharma is and what it is used for

Glucosamine Kern Pharma belongs to a group of medicines called other anti-inflammatory and anti-rheumatic non-steroidal compounds.

Glucosamine Kern Pharma is indicated to relieve symptoms caused by mild to moderate knee osteoarthritis.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Before taking Glucosamine Kern Pharma

Do not take Glucosamine Kern Pharma:

  • if you are allergic (hypersensitive) to glucosamine or any of the other ingredients of Glucosamine Kern Pharma,
  • if you are allergic (hypersensitive) to shellfish, as glucosamine is obtained from shellfish.

Take special care with Glucosamine Kern Pharma:

  • if you have altered glucose tolerance. More frequent monitoring of blood sugar levels may be necessary when starting treatment with glucosamine,
  • if you have any risk factors for heart or artery disease, as increased cholesterol levels have been observed in some patients treated with glucosamine,
  • if you have asthma. When starting treatment with glucosamine, keep in mind that symptoms may worsen,
  • if you have any kidney or liver impairment, as no investigations have been carried out in these conditions and, therefore, no dosage recommendations can be given.

You should consult your doctor to rule out the presence of other joint diseases for which other treatment should be considered.

Do not take Glucosamine Kern Pharma if you are under 18 years old.

Using other medicines

Tell your doctor or pharmacist if you are using or have recently used any other medicines, including those obtained without a prescription.

Caution is recommended if Glucosamine Kern Pharma is administered simultaneously with other medicines, especially with:

Certain types of medicines used to prevent blood clotting (e.g., warfarin, dicumarol, phenprocoumon, acenocoumarol, and fluindione). The effect of these medicines may be enhanced if used with glucosamine. Therefore, patients treated with these combinations should be closely monitored at the start or end of treatment with glucosamine.

Consult your doctor for proper advice.

Taking Glucosamine Kern Pharma with food and drinks

Dissolve the contents of the Glucosamine Kern Pharma sachet in a glass of water and take it once a day, preferably with meals.

Pregnancy and breastfeeding

Consult your doctor or pharmacist before using any medicine.

Glucosamine Kern Pharma should not be used during pregnancy. It may cause kidney and heart problems in your fetus.

The use of glucosamine during breastfeeding is not recommended.

Driving and using machines

No studies have been conducted on how Glucosamine Kern Pharma affects the ability to drive and use machines. However, if you experience dizziness or drowsiness when taking Glucosamine Kern Pharma, you should not drive or operate machinery (see section 4 "Possible side effects").

Important information about some of the ingredients of Glucosamine Kern Pharma:

Patients on low-sodium diets should note that this medicine contains 151 mg (6.57 mmol) of sodium per sachet.

This medicine contains sorbitol. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking/using this medicine.

This medicine may be harmful to people with phenylketonuria because it contains aspartame, which is a source of phenylalanine.

3. How to take Glucosamine Kern Pharma

Follow the administration instructions of Glucosamine Kern Pharma indicated by your doctor. Consult your doctor or pharmacist if you have any doubts.

Your doctor will adjust the dose according to your condition.

Administration method and dosage

The normal starting dose is one sachet (dissolved in a glass of water) once a day, preferably with meals.

For oral use.

Duration of treatment

Glucosamine is not indicated for the treatment of acute painful symptoms. Relief of symptoms (especially pain relief) may not be evident until after several weeks of treatment, and in some cases even longer. If you do not experience relief of symptoms after 2-3 months, the continuation of treatment with glucosamine should be reconsidered.

If you take more Glucosamine Kern Pharma than you should

If you take more Glucosamine Kern Pharma than you should, or if another person or child takes this medicine, tell your doctor or pharmacist.

Signs and symptoms of overdose with glucosamine include headache, dizziness, confusion, joint pain, nausea, vomiting, diarrhea, or constipation. Do not continue taking Glucosamine Kern Pharma if you experience any of the above symptoms.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service. Phone: (91) 562 04 20, indicating the medicine and the amount taken.

If you forget to take Glucosamine Kern Pharma

Do not take a double dose to make up for forgotten doses.

If you have any other questions about the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, Glucosamine Kern Pharma can cause side effects, although not everybody gets them.

You should interrupt treatment with glucosamine and go to your doctor immediately if you experience symptoms of angioedema, such as:

  • Swelling of the face, tongue, or throat.
  • Difficulty swallowing.
  • Hives and difficulty breathing.

The most frequently observed side effects are:

Frequent (affects 1 to 10 users in 100)

  • Headache.
  • Fatigue.
  • Nausea.
  • Abdominal pain.
  • Indigestion.
  • Diarrhea.
  • Constipation.

Uncommon (affects 1 to 10 users in 1,000)

  • Rash.
  • Itching.
  • Redness.

Frequency not known (cannot be estimated from the available data)

  • Dizziness.
  • Worsening of asthma symptoms.
  • Swelling in the ankles, legs, and feet.
  • Hives.
  • Increased cholesterol levels and worsening of blood sugar (glucose) levels in patients with diabetes mellitus.

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

5. Storage of Glucosamine Kern Pharma

Keep below 25°C.

Keep out of the reach and sight of children.

Do not use Glucosamine Kern Pharma after the expiration date stated on the sachet and packaging after the abbreviation "Cad". The expiration date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Further information

Composition of Glucosamine Kern Pharma:

  • The active ingredient is glucosamine. Each Glucosamine Kern Pharma sachet contains 1,500 mg of glucosamine sulfate as glucosamine sulfate sodium chloride equivalent to 1,178 mg of glucosamine.
  • The other ingredients are: aspartame (E951), sorbitol (E420), sodium, citric acid, and macrogol 4000.

Appearance of the product and packaging contents

The powder is white crystalline and odorless and is packaged in single-dose sachets.

Each package contains 20 or 30 sachets.

Only certain package sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder and manufacturer:

Kern Pharma, S.L.

Venus, 72 - Pol. Ind. Colon II

08228 Terrasa - Barcelona

Spain

Date of the last revision of this leaflet: September 2023.

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es

Online doctors for GLUCOSAMINE KERN PHARMA 1500 mg POWDER FOR ORAL SOLUTION

Discuss questions about GLUCOSAMINE KERN PHARMA 1500 mg POWDER FOR ORAL SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for GLUCOSAMINE KERN PHARMA 1500 mg POWDER FOR ORAL SOLUTION?
GLUCOSAMINE KERN PHARMA 1500 mg POWDER FOR ORAL SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in GLUCOSAMINE KERN PHARMA 1500 mg POWDER FOR ORAL SOLUTION?
The active ingredient in GLUCOSAMINE KERN PHARMA 1500 mg POWDER FOR ORAL SOLUTION is glucosamine. This information helps identify medicines with the same composition but different brand names.
Who manufactures GLUCOSAMINE KERN PHARMA 1500 mg POWDER FOR ORAL SOLUTION?
GLUCOSAMINE KERN PHARMA 1500 mg POWDER FOR ORAL SOLUTION is manufactured by Kern Pharma S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of GLUCOSAMINE KERN PHARMA 1500 mg POWDER FOR ORAL SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether GLUCOSAMINE KERN PHARMA 1500 mg POWDER FOR ORAL SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to GLUCOSAMINE KERN PHARMA 1500 mg POWDER FOR ORAL SOLUTION?
Other medicines with the same active substance (glucosamine) include ACENAM 1250 mg EFFERVSCENT TABLETS, CARTISORB 1500 mg POWDER FOR ORAL SOLUTION, DUARTRON 625 mg HARD CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media